Salesforce (CRM) stock could be a favorable purchase at this time. Why is that? Because it offers high margins – indicative ...

Salesforce is undergoing a pivotal AI-driven transformation with Agentforce and is expected to accelerate revenue growth.

Salesforce Inc (NYSE: CRM) shares moved higher Wednesday after the company secured a major win with Novartis selecting its Agentforce Life Sciences platform for global customer engagement, while BTIG ...

Dec 11 (Reuters) - The U.S. Food and Drug Administration has approved Flow Neuroscience's at-home brain stimulation device to treat depression, offering an alternative to typical antidepressants that ...

Company executives are shaping their information-technology budgets for next year. Microsoft looks set to be a major beneficiary from artificial-intelligence spending, but the news isn’t so good for ...

DA Davidson analyst Gil Luria raised the firm’s price target on Salesforce (CRM) to $235 from $225 and keeps a Neutral rating on the shares. The company reported lower than expected revenue this ...

Despite the fact that Salesforce CEO Marc Benioff talks about AI nonstop, regularly chimes in on the AI news of the day, and endlessly pushes his company’s AI platform, he seems worried that people ...